https://ckitsignal.com/index.p....hp/association-of-th
Ergo, in this research we aimed to evaluate the relationship of baseline serum granzyme B, as well as germline difference of this GZMB gene, with medical outcome to programmed mobile death protein 1 (PD-1) blockade. Methods A total of 347 clients with phase IV NSCLC whom began nivolumab treatment between Summer 2013 and June 2017 were prospectively included. Baseline serum and whole bloodstream had been available, making it possible for protein measurement and targ
Aimer
Commentaire
Partagez
